Sir George Alberti and Dr. Ele Ferrannini, former presidents of the European Association for the Study of Diabetes, talk with Dr. Anne Peters about how diabetes has evolved over the past 50 years.

What should we take away from the EASD studies on insulin pumps? Eric Renard, who chaired the main session on diabetic devices, gives us the highlights.

Solomon Tesfaye's lecture at the EASD Congress was the occasion to outline the issues in the diagnosis of diabetic neuropathy and how the spinal cord is involved in this condition.

Dr Bilazarian talks to Dr Desch, the PI of another sham-controlled renal denervation trial that missed its primary endpoint.

A large new study suggests that moderate coffee consumption can lower the risk for type 2 diabetes.

Drs. Harrington, Califf, and Yancy discuss their use of fitness tracking devices and the public health potential of wearable tech.

As he takes the reins as President of the National Kidney Foundation, Dr. Jeffrey Berns outlines ways to improve care in patients with chronic kidney disease and end-stage renal disease.

Guideline author Neil Stone explains why a risk discussion -- not a statin prescription -- is the foundation of the new cholesterol guidelines.